2002
DOI: 10.1177/1522162802005005001
|View full text |Cite
|
Sign up to set email alerts
|

Cryopreservation of Human Pancreatic Islets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 80 publications
1
15
0
Order By: Relevance
“…Similarly, by selecting for largest diameter, smooth-surfaced single cells after several days in culture, it is likely that we were choosing for study the most viable cells and avoiding the bulk of cells undergoing apoptosis. Recent improvements in cryopreservation technique include: reduction in the concentration of DMSO as cryopreservant [29], substitution of ethylene glycol or trehalose as the cryopreservant [30,31], and addition of antioxidants such as beraprost sodium, butylated hydroxyanisole or ascorbic acid-2 glucoside to the cryopreservant [32][33][34].…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, by selecting for largest diameter, smooth-surfaced single cells after several days in culture, it is likely that we were choosing for study the most viable cells and avoiding the bulk of cells undergoing apoptosis. Recent improvements in cryopreservation technique include: reduction in the concentration of DMSO as cryopreservant [29], substitution of ethylene glycol or trehalose as the cryopreservant [30,31], and addition of antioxidants such as beraprost sodium, butylated hydroxyanisole or ascorbic acid-2 glucoside to the cryopreservant [32][33][34].…”
Section: Discussionmentioning
confidence: 99%
“…Cell viabilities after cryopreservation were as‐sessed by an AO/PI assay, as previously reported (10). Thawed human islets after cryopreservation were suspended with CRMI medium supplemented with 10% FBS and seeded on six‐well plates at a density of 100 islets/well.…”
Section: Methodsmentioning
confidence: 99%
“…[ 19 ] These results demonstrated that suboptimal cryopreservation process can cause cryoinjuries (i.e., ice injury and solute injury) to the cells and loss of islet functionalities, which warranted the need of further improvements of the islet cryopreservation protocols. [ 3,4,45 ] To understand how cryopreservation and microencapsulation affect the islet functionality, we fi rst measured the ATP and static insulin release values of bare islets (B), encapsulated islets (E), bare islets cryopreserved and stored at −80 °C for 1 or 7 d (B1d or B7d), encapsulated islets cryopreserved and stored at −80 °C for 1 or 7 d (E1d or E7d), and encapsulated islets cryopreserved with trehalose (additional CPA to the routinely used DMSO medium) and stored at −80 °C for 1 or 7 d (ET1d or ET7d) for comparison studies. Figure 3 shows the ATP value of islets under different protocols for encapsulated/bare islets with or without cryopreservation.…”
Section: Atp and Static Insulin Release Measurementsmentioning
confidence: 99%
“…[ 1 ] In the last decade, transplantation of pancreatic islets, such as the well-known "Edmonton protocol", has been considered as the most physiologically advantageous solution for glucose homeostasis in clinical treatments of selected patients with type 1 diabetes mellitus, which can eliminate insulin injection, reverse neurovascular complications, and even prevent end-stage organ failure. [2][3][4][5][6] In such treatments, suffi cient islet equivalents with high quality are critical for positive clinical outcomes. For example, the Edmonton protocol requires a cumulative islet mass of 10 000 islet equivalents or more per kilogram of body weight of the recipient.…”
Section: Introductionmentioning
confidence: 99%